A. Ardzinski

发表

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013, Antimicrobial Agents and Chemotherapy.

Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein.

A. Lee, S. Majeski, A. Cuconati, 2021, Antiviral research.

Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation

Quanxin Long, N. Snead, A. Lee, 2018, Antimicrobial Agents and Chemotherapy.

Genotypic and Phenotypic Analyses of Hepatitis C Virus Variants Observed in Clinical Studies of VX-222, a Nonnucleoside NS5B Polymerase Inhibitor

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2014, Antimicrobial Agents and Chemotherapy.

Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.

B. G. Rao, G. Iyer, L. Chan, 2016, Journal of medicinal chemistry.

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

A. Bisceglie, D. Bartels, M. Koziel, 2012 .

ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection.

N. Snead, X. Ye, A. Cuconati, 2018, ACS infectious diseases.

Preclinical antiviral drug combination studies utilizing novel orally bioavailable investigational agents for chronic hepatitis B infection: AB-506, a next generation HBV capsid inhibitor, and AB-452, a HBV RNA destabilizer

K. Mcclintock, S. Majeski, D. Gotchev, 2018 .

Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.

G. Iyer, L. Chan, C. Yannopoulos, 2016, Journal of medicinal chemistry.